Successful Management of Dadru Kushtha (Tinea Corporis) with Ethnobotanical and Herbo-Mineral Approach: A Case Study

Abstract

Background: Dadru Kushtha is classified in Ayurvedic classics as a Kshudra Kushtha with predominant Kapha and Pitta Dosha vitiation, manifesting as Kandu (intense itching), Raga (erythema), and Utsanna Mandala (elevated, ring- shaped lesions), secondary to derangement of Twak, Rakta, Mamsa, and Lasika Dushyas. Its closest modern correlate is tinea corporis (ICD-10: B35.4), a superficial dermatophyte infection commonly caused by Trichophyton rubrum and related species that colonize the keratinized skin layers, forming characteristic annular, scaly plaques. In an era of rising antifungal resistance and frequent recurrence after synthetic treatment, there is a pressing need for holistic, root-cause- directed therapeutic approaches.
Case Summary: A 57-year-old male presented to the Outpatient Department (OPD) in February 2026 with a 2-week history of severe itching, irritation, and erythema over both forearms, accompanied by loss of sleep and appetite. He was subsequently admitted as an In-Patient Department (IPD) case at Parul Institute of Ayurved, Parul University, Vadodara, Gujarat.
Intervention: Shamana (palliative and corrective) therapy was administered for 15 days, comprising: internal medications — Tab. Eranda Bhrishta Haritaki, Tab. Gandhaka Rasayana, Tab. Panchatiktaghrita Guggulu with Panchatikta Kashaya 15 ml, and Tab. Agni Tundi Vati, along with an external Lepa (medicated paste) of Tankana Bhasma, Gandhaka, Neem, and Haridra kalka in Ghrita Kumari Swarasa, applied twice daily.
Outcomes: Marked and progressive relief was documented in itching, irritation, and erythema; lesion spread was significantly reduced; and sleep quality and appetite improved. One post-discharge follow-up confirmed ongoing regression of the condition with no new lesions.
Conclusion: This case demonstrates the clinical efficacy of a well-reasoned, multi-target Ayurvedic Shamana protocol in managing Dadru Kushtha, offering a safe, recurrence-preventing alternative to conventional antifungal monotherapy.